APPLICATION OF METHYLENE BLUE IN THE TREATMENT OF COVID-19
A solution of methylene blue (MB) has a proven efficacy against the SARS-CoV-2 virus in vitro and is used to inactivate blood components. When used in patients with proven or suspected coronavirus infection at the initial stage of the disease, MB has shown clinical and laboratory efficacy as an etiotropic drug. When used in patients with already severe lung damage, the effectiveness of MB was not noted. Taking into account the absence of side effects, MB can be recommended for etiotropic therapy for COVID-19 in the early stages of the disease in the off-label mode.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.